Cargando…

Quantification of Gleason Pattern 4 at MRI-Guided Biopsy to Predict Adverse Pathology at Radical Prostatectomy in Intermediate-Risk Prostate Cancer Patients

SIMPLE SUMMARY: The amount of Gleason pattern 4 (GP4) in biopsy material may be used for individual risk stratification in prostate cancer patients. The utility of this parameter is potentially most significant in patients that fall into the intermediate-risk category, in whom various alternative st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamecki, Hubert, Mielczarek, Łukasz, Szempliński, Stanisław, Dębowska, Małgorzata, Rajwa, Paweł, Baboudjian, Michael, Klemm, Jakob, Rivas, Juan Gómez, Modzelewska, Elza, Tayara, Omar, Malewski, Wojciech, Szostek, Przemysław, Poletajew, Sławomir, Kryst, Piotr, Sosnowski, Roman, Nyk, Łukasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670701/ https://www.ncbi.nlm.nih.gov/pubmed/38001723 http://dx.doi.org/10.3390/cancers15225462

Ejemplares similares

The Impact of the Ongoing COVID-19 Epidemic on the Increasing Risk of Adverse Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy
por: Nyk, Łukasz, et al.
Publicado: (2022)

Patient-reported pain associated with grid-based transperineal magnetic resonance imaging (MRI)/ultrasound (US) software fusion biopsy of the prostate under local anesthesia: a multicenter experience
por: Szempliński, Stanisław, et al.
Publicado: (2023)

Predictors of Clinically Significant Prostate Cancer in Patients with PIRADS Categories 3–5 Undergoing Magnetic Resonance Imaging-Ultrasound Fusion Biopsy of the Prostate
por: Szempliński, Stanisław, et al.
Publicado: (2022)

High-Intensity Focused-Ultrasound Focal Therapy Versus Laparoscopic Radical Prostatectomy: A Comparison of Oncological and Functional Outcomes in Low- and Intermediate-Risk Prostate Cancer Patients
por: Nyk, Łukasz, et al.
Publicado: (2022)

Prostate Biopsy in the Case of PIRADS 5—Is Systematic Biopsy Mandatory?
por: Malewski, Wojciech, et al.
Publicado: (2023)

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
por: Nyk, Łukasz, et al.
Publicado: (2021)

Diagnostic Performance of Preoperative Choline-PET/CT in Patients Undergoing Salvage Lymph Node Dissection for Recurrent Prostate Cancer: A Multicenter Experience
por: Nyk, Łukasz, et al.
Publicado: (2022)

Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist?
por: Skrzypczyk, Michał Andrzej, et al.
Publicado: (2014)

Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival
por: Kamecki, Hubert, et al.
Publicado: (2023)

Multi-Drug Resistant Bacteria as Aetiological Factors of Infections in a Tertiary Multidisciplinary Hospital in Poland
por: Poletajew, Sławomir, et al.
Publicado: (2021)

Pushing the boundaries: emerging role of radical prostatectomy as part of multimodal treatment for oligometastatic prostate cancer
por: Sosnowski, Roman, et al.
Publicado: (2023)

3.0-T multiparametric magnetic resonance imaging modifies the template of endoscopic, conventional radical prostatectomy in all cancer risk categories 
por: Kozikowski, Mieszko, et al.
Publicado: (2018)

Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?
por: Poletajew, Sławomir, et al.
Publicado: (2020)

Non-Invasive Biomarkers in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma—A Systematic Review
por: Białek, Łukasz, et al.
Publicado: (2022)

The impact of coronavirus disease 2019 (COVID-19) pandemic on urologic cancer care: did we throw the baby out with the bathwater?
por: Kamecki, Hubert, et al.
Publicado: (2023)

Blood loss during laparoscopic radical prostatectomy – is it significant or not?
por: Poletajew, Sławomir, et al.
Publicado: (2012)

The correlation between the gleason score of the biopsy and that of the prostatectomy patch
por: Bai, W., et al.
Publicado: (2021)

Active surveillance for low-risk prostate cancer: well established, yet avoided?
por: Sosnowski, Roman, et al.
Publicado: (2022)

Oncologic Outcomes of Patients With Gleason Score 7 and Tertiary Gleason Pattern 5 After Radical Prostatectomy
por: Leng, Yi-Hsueh, et al.
Publicado: (2013)

Reporting Gleason grade/score in synoptic reports of radical prostatectomies
por: Renshaw, Andrew A., et al.
Publicado: (2016)

TGF-β and microRNA Interplay in Genitourinary Cancers
por: Boguslawska, Joanna, et al.
Publicado: (2019)

Bladder perforation during transurethral resection of bladder tumour is not a result of a deficient structure of the bladder wall
por: Poletajew, Sławomir, et al.
Publicado: (2020)

Clinical significance of surgical margin status in patients subjected to radical prostatectomy
por: Dobruch, Jakub, et al.
Publicado: (2012)

Factors predicting Gleason score 6 upgrading after radical prostatectomy
por: Milonas, Daimantas, et al.
Publicado: (2011)

Significance of tertiary Gleason pattern 5 in patients with Gleason score 7 after radical prostatectomy: a retrospective cohort study
por: Li, Jiakun, et al.
Publicado: (2019)

Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model
por: Taguchi, Satoru, et al.
Publicado: (2020)

Human kidney injury molecule-1 as a urine biomarker differentiating urothelial and renal cell carcinoma
por: Białek, Łukasz, et al.
Publicado: (2021)

piRNAs and PIWI Proteins as Diagnostic and Prognostic Markers of Genitourinary Cancers
por: Hanusek, Karolina, et al.
Publicado: (2022)

Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

Diagnostic and treatment delays among patients with primary bladder cancer in Poland: a survey study
por: Mielczarek, Łukasz, et al.
Publicado: (2020)

Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
por: Geybels, Milan S., et al.
Publicado: (2016)

Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy
por: Fiorentino, Vincenzo, et al.
Publicado: (2020)

Higher Prostate Weight Is Inversely Associated with Gleason Score Upgrading in Radical Prostatectomy Specimens
por: Reis, Leonardo Oliveira, et al.
Publicado: (2013)

Is Small Prostate Volume a Predictor of Gleason Score Upgrading after Radical Prostatectomy?
por: Chung, Mun Su, et al.
Publicado: (2013)

The Association of Fatty Acid Levels and Gleason Grade among Men Undergoing Radical Prostatectomy
por: Zhao, Zhiguo, et al.
Publicado: (2016)

Predictive Factors and Oncologic Outcome of Downgrade to Pathologic Gleason Score 6–7 after Radical Prostatectomy in Patients with Biopsy Gleason Score 8–10
por: Chung, Doo Yong, et al.
Publicado: (2019)

Radical prostatectomy in locally advanced cancer – an indispensable onset of multimodal therapy?
por: Malewski, Wojciech, et al.
Publicado: (2017)

En-bloc resection of urinary bladder tumour – a prospective controlled multicentre observational study
por: Poletajew, Sławomir, et al.
Publicado: (2020)

The Long-Term Outcomes after Radical Prostatectomy of Patients with Pathologic Gleason 8–10 Disease
por: Lewinshtein, Dan, et al.
Publicado: (2012)

Analysis of risk factors for Gleason score upgrading after radical prostatectomy in a Chinese cohort
por: Zhang, Baoling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gd1pkpse3ddb2peueuhrs57d3e